Line 175: | Line 175: | ||
<th scope="row" style="background-color: #dadadc">2</th> | <th scope="row" style="background-color: #dadadc">2</th> | ||
<td><b>Collaboration –</b> Meet all the deliverables on the Competition Deliverables page</td> | <td><b>Collaboration –</b> Meet all the deliverables on the Competition Deliverables page</td> | ||
− | <td>At the beginning of iGEM, we created a <a href="https://static.igem.org/mediawiki/2017/2/27/T--Newcastle--BB_collab_flyer.png">flyer</a> showcasing the strengths of our team and the various ways we could help other teams. As a result of this, we were contacted by three teams: <a href="https://2017.igem.org/Team:Edinburgh_OG/Collaborations">Edinburgh overgraduate team</a>, <a href="https://2017.igem.org/Team:Exeter/Collaborations">Exeter</a>, and <a href="https://2017.igem.org/Team:Evry_Paris-Saclay/Collaborations#about">Evry Paris-Saclay</a>. For the Edinburgh team, we used our modelling knowledge to help fix their model. We aided the Exeter team by repeating one of their experiments, and they gathered single-cell fluorescence data for our deGFP construct using their FACS machine. Finally, Paris designed a novel psicose-regulated promoter to be used in a biosensor. We then incorporated their promoter into our framework so that many different variants of a psicose biosensor could be designed, made and tested. Check out our <a href="https://2017.igem.org/Team:Newcastle/Collaborations">collaboration page</a> for more information</td> | + | <td><p>At the beginning of iGEM, we created a <a href="https://static.igem.org/mediawiki/2017/2/27/T--Newcastle--BB_collab_flyer.png">flyer</a> showcasing the strengths of our team and the various ways we could help other teams. As a result of this, we were contacted by three teams: <a href="https://2017.igem.org/Team:Edinburgh_OG/Collaborations">Edinburgh overgraduate team</a>, <a href="https://2017.igem.org/Team:Exeter/Collaborations">Exeter</a>, and <a href="https://2017.igem.org/Team:Evry_Paris-Saclay/Collaborations#about">Evry Paris-Saclay</a>. For the Edinburgh team, we used our modelling knowledge to help fix their model. We aided the Exeter team by repeating one of their experiments, and they gathered single-cell fluorescence data for our deGFP construct using their FACS machine. Finally, Paris designed a novel psicose-regulated promoter to be used in a biosensor. We then incorporated their promoter into our framework so that many different variants of a psicose biosensor could be designed, made and tested. Check out our <a href="https://2017.igem.org/Team:Newcastle/Collaborations">collaboration page</a> for more information</p></td> |
</tr> | </tr> | ||
<tr> | <tr> | ||
<th scope="row" style="background-color: #dadadc">3</th> | <th scope="row" style="background-color: #dadadc">3</th> | ||
<td><b>Human Practices –</b> Create a page on your team wiki with clear attribution of each aspect of your project.</td> | <td><b>Human Practices –</b> Create a page on your team wiki with clear attribution of each aspect of your project.</td> | ||
− | <td>Our human practices work has focused on addressing technology uptake, which is one of the challenges that we identified to biosensor development and deployment. This took place in three main stages. First, we determined the current state of dialogue by consulting previous dialogue studies and reviewing how language is used in the media. We then generated our own guidelines to help future researchers to develop dialogue in a constructive way. Finally, we put this into practise by creating activities and sharing our work in a way that established a dialogue and encouraged discussion. Check out our <a href="https://2017.igem.org/Team:Newcastle/HP/Silver">Human Practices (Silver) page</a> for more information.</td> | + | <td><p>Our human practices work has focused on addressing technology uptake, which is one of the challenges that we identified to biosensor development and deployment. This took place in three main stages. First, we determined the current state of dialogue by consulting previous dialogue studies and reviewing how language is used in the media. We then generated our own guidelines to help future researchers to develop dialogue in a constructive way. Finally, we put this into practise by creating activities and sharing our work in a way that established a dialogue and encouraged discussion. Check out our <a href="https://2017.igem.org/Team:Newcastle/HP/Silver">Human Practices (Silver) page</a> for more information.</p></td> |
</tr> | </tr> | ||
Line 191: | Line 191: | ||
<th scope="row" style="background-color:#fddd85">1</th> | <th scope="row" style="background-color:#fddd85">1</th> | ||
<td><b>Integrated Human Practices –</b> Expand on your silver medal activity by demonstrating how you have integrated the investigated issues into the design and/or execution of your project.</td> | <td><b>Integrated Human Practices –</b> Expand on your silver medal activity by demonstrating how you have integrated the investigated issues into the design and/or execution of your project.</td> | ||
− | <td> | + | <td><p> |
Sensynova was a project founded in Human Practices. Each branch of our project is rooted in a barrier to biosensor implementation identified by in-depth conversations with stakeholders. We identified not only technical issues, but also societal issues, as these are equally important in ensuring successful implementation of biosensor projects. The aims of our human practices were to: | Sensynova was a project founded in Human Practices. Each branch of our project is rooted in a barrier to biosensor implementation identified by in-depth conversations with stakeholders. We identified not only technical issues, but also societal issues, as these are equally important in ensuring successful implementation of biosensor projects. The aims of our human practices were to: | ||
<ol> | <ol> | ||
Line 199: | Line 199: | ||
</ol> | </ol> | ||
To achieve these aims, we emailed, skyped and attended conferences to speak to stakeholders in biosensor development, from the early research stage to the end-user. Check out our <a href="https://2017.igem.org/Team:Newcastle/HP/Gold_Integrated">integrated human practices page</a> for more information | To achieve these aims, we emailed, skyped and attended conferences to speak to stakeholders in biosensor development, from the early research stage to the end-user. Check out our <a href="https://2017.igem.org/Team:Newcastle/HP/Gold_Integrated">integrated human practices page</a> for more information | ||
− | </td> | + | </p></td> |
</tr> | </tr> | ||
<tr> | <tr> | ||
Line 228: | Line 228: | ||
<th scope="row" style="background-color:#fddd85">3</th> | <th scope="row" style="background-color:#fddd85">3</th> | ||
<td><b>Model your project –</b> Convince the judges your project's design and/or implementation is based on insight you have gained from modelling.</td> | <td><b>Model your project –</b> Convince the judges your project's design and/or implementation is based on insight you have gained from modelling.</td> | ||
− | <td>For our project, we built three types of models. The first was an agent-based model which simulated our multicellular biosensor framework. This model gave insight into the optimal ratio of cell-types to have in the system. This information was used during experimental characterisation to optimise our system. Our second model was a statistical, multifactorial Design of Experiments (DoE) approach towards optimising Cell-Free Protein Synthesis (CFPS) systems. This statistical model was used to generate an experimental design to gather data on the importance of certain supplements in CFPS systems, and then use the experimental data to optimise CFPS systems. Find out more about our models <a href="https://2017.igem.org/Team:Newcastle/Model">here</a>.</td> | + | <td><p>For our project, we built three types of models. The first was an agent-based model which simulated our multicellular biosensor framework. This model gave insight into the optimal ratio of cell-types to have in the system. This information was used during experimental characterisation to optimise our system. Our second model was a statistical, multifactorial Design of Experiments (DoE) approach towards optimising Cell-Free Protein Synthesis (CFPS) systems. This statistical model was used to generate an experimental design to gather data on the importance of certain supplements in CFPS systems, and then use the experimental data to optimise CFPS systems. Find out more about our models <a href="https://2017.igem.org/Team:Newcastle/Model">here</a>.</p></td> |
</tr> | </tr> | ||
<tr> | <tr> | ||
<th scope="row" style="background-color:#fddd85">4</th> | <th scope="row" style="background-color:#fddd85">4</th> | ||
<td><b>Demonstrate your work –</b> Convince the judges that your project works.</td> | <td><b>Demonstrate your work –</b> Convince the judges that your project works.</td> | ||
− | <td>We have produced a functional multicellular biosensor based on bacterial quorum sensing. Each part has been tested and characterised singularly. The co-culture of the 3 bacterial types are proved to form a working biosensing device. More details can be found <a href="https://2017.igem.org/Team:Newcastle/Results">here</a>.</td> | + | <td><p>We have produced a functional multicellular biosensor based on bacterial quorum sensing. Each part has been tested and characterised singularly. The co-culture of the 3 bacterial types are proved to form a working biosensing device. More details can be found <a href="https://2017.igem.org/Team:Newcastle/Results">here</a>.</p></td> |
</tr> | </tr> | ||
</tbody> | </tbody> |
Revision as of 16:35, 29 October 2017
spacefill
spacefill
Medal Requirements
Medal | Criteria | Explanation |
---|---|---|
Bronze | All must be met | |
1 | Register and Attend – Register for iGEM and attend the Giant Jamboree. | Newcastle iGEM team has registered and will be attending the Giant Jamboree in Boston. |
2 | Deliverables – Meet all the deliverables on the Competition Deliverables page | A team wiki, poster, presentation and project attributions were made. The safety form, judging form and registry pages were completed. |
3 | Attribution – Create a page on your team wiki with clear attribution of each aspect of your project. | Our Attributions page is here. |
4 | Characterise/Contribution – Participate in the Interlab Measurement Study and/or improve the characterisation of an existing BioBrick Part or Device and enter this information on that part's Main Page in the Registry. | Our team participated in the Interlab Measurement Study. |
Silver | All must be met | |
1 | Validated Part/Validated Contribution – Register for iGEM and attend the Giant Jamboree. |
|
2 | Collaboration – Meet all the deliverables on the Competition Deliverables page | At the beginning of iGEM, we created a flyer showcasing the strengths of our team and the various ways we could help other teams. As a result of this, we were contacted by three teams: Edinburgh overgraduate team, Exeter, and Evry Paris-Saclay. For the Edinburgh team, we used our modelling knowledge to help fix their model. We aided the Exeter team by repeating one of their experiments, and they gathered single-cell fluorescence data for our deGFP construct using their FACS machine. Finally, Paris designed a novel psicose-regulated promoter to be used in a biosensor. We then incorporated their promoter into our framework so that many different variants of a psicose biosensor could be designed, made and tested. Check out our collaboration page for more information |
3 | Human Practices – Create a page on your team wiki with clear attribution of each aspect of your project. | Our human practices work has focused on addressing technology uptake, which is one of the challenges that we identified to biosensor development and deployment. This took place in three main stages. First, we determined the current state of dialogue by consulting previous dialogue studies and reviewing how language is used in the media. We then generated our own guidelines to help future researchers to develop dialogue in a constructive way. Finally, we put this into practise by creating activities and sharing our work in a way that established a dialogue and encouraged discussion. Check out our Human Practices (Silver) page for more information. |
Gold | At least 2 must be met | |
1 | Integrated Human Practices – Expand on your silver medal activity by demonstrating how you have integrated the investigated issues into the design and/or execution of your project. | Sensynova was a project founded in Human Practices. Each branch of our project is rooted in a barrier to biosensor implementation identified by in-depth conversations with stakeholders. We identified not only technical issues, but also societal issues, as these are equally important in ensuring successful implementation of biosensor projects. The aims of our human practices were to:
|
2 | Improve a previous part or project – Improve the function of an existing BioBrick Part or existing iGEM project and display your achievement on your wiki. |
|
3 | Model your project – Convince the judges your project's design and/or implementation is based on insight you have gained from modelling. | For our project, we built three types of models. The first was an agent-based model which simulated our multicellular biosensor framework. This model gave insight into the optimal ratio of cell-types to have in the system. This information was used during experimental characterisation to optimise our system. Our second model was a statistical, multifactorial Design of Experiments (DoE) approach towards optimising Cell-Free Protein Synthesis (CFPS) systems. This statistical model was used to generate an experimental design to gather data on the importance of certain supplements in CFPS systems, and then use the experimental data to optimise CFPS systems. Find out more about our models here. |
4 | Demonstrate your work – Convince the judges that your project works. | We have produced a functional multicellular biosensor based on bacterial quorum sensing. Each part has been tested and characterised singularly. The co-culture of the 3 bacterial types are proved to form a working biosensing device. More details can be found here. |